Malaria Vaccine Study in Rhesus Macaques
Author Information
Author(s): Mahdi Abdel Hamid Muzamil, Remarque Edmond J, El Hassan Ibrahim M, Hussain Ayman A, Narum David L, Thomas Alan W, Kocken Clemens HM, Weiss Walter R, Faber Bart W
Primary Institution: Biomedical Primate Research Centre
Hypothesis
Does a DNA prime, poxvirus boost vaccination strategy induce functional antibody responses against malaria blood stage antigens?
Conclusion
The study found that while vaccination induced low levels of malaria growth inhibitory antibodies, these levels significantly increased after sporozoite challenge, but did not correlate with protection.
Supporting Evidence
- 60% of vaccinated monkeys were protected from lethal malaria infection.
- Antibody levels increased over 30-fold after sporozoite challenge.
- No significant difference in growth inhibition levels between protected and not protected animals.
Takeaway
Researchers gave a vaccine to monkeys to see if it would help them fight malaria. After they got sick, the monkeys made a lot more antibodies, but it didn't help them stay healthy.
Methodology
Rhesus macaques were vaccinated with a four-component vaccine and then challenged with P. knowlesi sporozoites; antibody titres and growth inhibition were measured.
Potential Biases
Potential bias in the interpretation of antibody levels and their correlation with protection due to the small sample size.
Limitations
The study could not establish a correlation between antibody levels and protection, and the sample size was limited.
Participant Demographics
Rhesus macaques were used in the study.
Statistical Information
P-Value
9.9e-7
Confidence Interval
95% CI: 15-80
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website